5%+ major-holding disclosures
- 이환철24.43%2026-09-18 · 증감 +2.51%p
- 나우IB9.60%2026-09-10 · 증감 -2.40%p
- 브이아이피자산운용5.36%2026-06-10 · 증감 -1.26%p
₩57,800+10.31%
2026-10-07 closeL&C BIO's company information is shown as of 2026-10-07. It is a security listed on KOSDAQ, ticker 290650. There are 14 published related companies.
About this company
L&C BIO last closed at ₩57,800 (+10.31%) on 2026-10-07. Listed on KOSDAQ.
Who held it · filings
Filed recordA historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.
US 13F is quarterly and may be filed up to 45 days later.
Other stocks held by the same investors
A filing-based shared-holder record, not investment advice.
- 알톤KRA123750 →
Shared holders: 나우IB
Suppliers, competitors and related stocks
- 메디톡스Competitor
보툴리눔 톡신·미용/재생의학 영역에서 경쟁
- 휴젤Competitor
미용의료·필러/톡신 시장에서 경쟁
- 대웅제약Competitor
보툴리눔 톡신 및 에스테틱 관련 경쟁
- LG화학Competitor
필러·에스테틱 바이오소재 시장 경쟁
- 휴메딕스Competitor
HA필러 등 미용의료 제품 경쟁
- 한미약품Competitor
재생의학·바이오의약품 개발 측면에서 경쟁
- 셀트리온Competitor
바이오의약품 개발·상용화 역량 측면에서 경쟁
- 삼성바이오로직스Competitor
바이오 산업 전반에서 국내 대형 경쟁사
- 알테오젠Related theme
재생의학·바이오소재/플랫폼 확장과 같은 바이오 테마
- 파마리서치Related theme
재생의학·피부/미용의료 시장의 대표 테마 종목
- 메디포스트Related theme
세포치료·재생의학 관련 테마
- Becton DickinsonCompetitor
글로벌 의료기기·재생의료/소모품 영역에서 경쟁
- Allergan AestheticsCompetitor
글로벌 에스테틱·필러/미용의료 시장 경쟁
- Johnson & JohnsonSupplier
의료·수술 재료 및 글로벌 헬스케어 밸류체인 연관
Major stocks in the same sector
2026-10-07 dataset
Disclosed suppliers
2026-03-24 dataset
📦 ETFs holding this stock
by weight · top-10 constituents basisPassive money holding this stock ≈ KRW 1.7B · 1w net inflow ≈ +KRW 0.0B(lower bound — top-10 basis, not a forecast)
Factual holdings info from daily disclosures — not a recommendation.
Look up another stock →Quantus Signal · live data · not investment advice · Privacy Policy